Patents by Inventor Hans-Joachim Kabbe

Hans-Joachim Kabbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5459143
    Abstract: N,N-Disubstitued piperazines are prepared by reacting either the appropriately substituted furans or the N-unsubstituted pyrrolidines with aminoalkylpiperazines. The substances according to the invention can be employed as active agents in medicaments, in particular for the production of immunomodulators.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: October 17, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Eckhard Schwenner, Gaetan Ladouceur, Hans-Joachim Kabbe, Thomas M. Aune
  • Patent number: 5411960
    Abstract: Substituted pyrroloanthracenes are prepared by reacting either furanoanthracenes or N-unsubstituted pyrroloanthracenes with appropriately substituted alkylamines. The compounds can be employed as active ingredients in medicaments, in particular as immunomodulators.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: May 2, 1995
    Assignee: Bayer Aktiengesellschaft
    Inventors: Eckhard Schwenner, Gaetan Ladouceur, Hans-Joachim Kabbe, Thomas M. Aune
  • Patent number: 5409932
    Abstract: The piperazine-substituted pyrroloanthracenes are prepared by reacting either furanoanthracenes with piperazinalkylamines or reacting unsubstituted pyrroloanthracenes first with dihalogenoalkyl compounds and then with appropriately substituted piperazines or by reacting furan derivatives first with piperazinalkylamines and then condensing with anthracenes. The new compounds can be employed as active ingredients in medicaments, in particular in immunomodulators.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: April 25, 1995
    Assignee: Bayer AG
    Inventors: Eckhard Schwenner, Gaetan Ladouceur, Hans-Joachim Kabbe, Thomas M. Aune
  • Patent number: 5221681
    Abstract: The present invention relates to new substituted benzoxazepines and benzothiazepines of the general formula I ##STR1## in which X, R.sup.1, R.sup.2 and R.sup.3 have the meaning given in the description, processes for their preparation and their use in medicaments having vaso- and muscle-relaxing properties, in particular as circulatory agents.
    Type: Grant
    Filed: January 16, 1992
    Date of Patent: June 22, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Helmut Heitzer, Andreas Knorr, Claudia Hirth-Dietrich
  • Patent number: 4980343
    Abstract: Therapeutic compositions comprising the new derivatives of aminooxodihydroisoindolo-quinazoline of the formula ##STR1## are useful in inhibiting the growth of colon and rectal tumors.
    Type: Grant
    Filed: June 20, 1989
    Date of Patent: December 25, 1990
    Assignee: Bayer Aktiengesellschaft
    Inventors: Valentino Stella, Laman A. Al-Razzak, Hans-Joachim Kabbe
  • Patent number: 4757072
    Abstract: A carcinostatic composition useful in inhibiting the growth of colon and/or rectal tumors comprising 8-amino-12-oxo-10, 12-dihydroindolo [1,2-b]-quinazoline of the formula: ##STR1##
    Type: Grant
    Filed: March 17, 1987
    Date of Patent: July 12, 1988
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Robert Bierling, Ghanem Atassi
  • Patent number: 4659737
    Abstract: Substituted benzopyrans of the formula ##STR1## in which --A-- is a single or double bond,X is a direct bond, optionally substituted methylene, oxygen or optionally substituted --NH--, and the various other radicals can have various meanings,or pharmaceutically acceptable addition salts thereof, which possess anti-hypertensive activity.
    Type: Grant
    Filed: March 25, 1985
    Date of Patent: April 21, 1987
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Ulrich Niewohner, Arno Widdig, Andreas Knorr, Bernward Garthoff, Stanislav Kazda
  • Patent number: 4647579
    Abstract: Novel substituted 4-hydroxy-benzopyrans of the formula ##STR1## in which X is a single bond, ##STR2## and the other radicals can have various meanings, or pharmaceutically acceptable addition salts thereof, which are active on the circulation system.
    Type: Grant
    Filed: March 21, 1985
    Date of Patent: March 3, 1987
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Arno Widdig, Ulrich Niewohner, Andreas Knorr, Bernward Garthoff, Stanislav Kazda
  • Patent number: 4644000
    Abstract: 2-(1H-pyrazol-1-yl)-4-(3H)-quinazolinones of the formula ##STR1## in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are identical or different and denote hydrogen, halogen, alkyl, alkoxy, hydroxyl or amino andR.sup.5 represents hydrogen or a cation,are active compounds in microbicidal agents.
    Type: Grant
    Filed: March 25, 1985
    Date of Patent: February 17, 1987
    Assignee: Bayer Aktiengesellschaft
    Inventors: Walter Gauss, Hans-Joachim Kabbe, Wilfried Paulus, Hans-Jurgen Rosslenbroich, Wilhelm Brandes
  • Patent number: 4622339
    Abstract: Norbornane- and norbornene-carboxylic acid amides of the formula ##STR1## in which ##STR2## represents the part structure ##STR3## A represents a ##STR4## or --CH.sub.2 --CH.sub.2 -- group, R.sup.1 and R.sup.2 each independently is hydrogen or an alkyl radical with 1-6 carbon atoms,R.sup.3 is alkyl or alkenyl which has 1-8 carbon atoms and is optionally substituted by halogen or alkyl with 1 or 2 carbon atoms, cycloalkyl or cycloalkeny wtih 3 to 7 carbon atoms, an aromatic radical which has 6 or 10 carbon atoms and and is optionally substituted by halogen, by alkyl with 1 or 2 carbon atoms or by halogenoalkyl with 1 or 2 carbon atoms, or is a five-membered or six-membered heteroaromatic radical,R.sup.4 is hydrogen or a hydroxyl group,R.sup.5 and R.sup.6 each independently is hydrogen or alkyl with 1 to 4 carbon atoms, andn is a number from 2 to 6,and, if R.sup.1 is hydrogen, also physiologically acceptable salts thereof, perform as thromboxan antagonists.
    Type: Grant
    Filed: January 11, 1985
    Date of Patent: November 11, 1986
    Assignee: Bayer Aktiengesellschaft
    Inventors: Folker Lieb, Hermann Oediger, Hans-Joachim Kabbe, Ulrich Niewohner, Elisabeth Perzborn, Friedel Seuter
  • Patent number: 4574124
    Abstract: The invention relates to alkylurea derivatives of Formula (I), as defined in the specification, which alkylurea derivatives are useful as hypolipaemic agents. Also included in the invention are methods for the manufacture of said alkylurea derivatives compositions and medicaments containing said alkylurea derivatives and methods for the use of said alkylurea derivatives.
    Type: Grant
    Filed: January 23, 1984
    Date of Patent: March 4, 1986
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Hans-Peter Krause, Rudiger Sitt
  • Patent number: 4563458
    Abstract: The invention relates to substituted 4-aminomethylene-chromans and chromens of Formula (I) infra, as well as methods for making of said chromans and chromens, compositions containing said chromans and chromens and methods for the use of said chromans, chromens and compositions containing said chromans and chromens. The compounds and compositions of the invention are useful for their circulation influencing activity.
    Type: Grant
    Filed: December 13, 1983
    Date of Patent: January 7, 1986
    Assignee: Bayer Aktiengesellschaft
    Inventors: Arno Widdig, Hans-Joachim Kabbe, Andreas Knorr, Ulrich Benz
  • Patent number: 4510156
    Abstract: The invention relates to alkylurea derivatives of Formula (I), as defined in the specification, which alkylurea derivatives are useful as hypolipaemic agents. Also included in the invention are methods for the manufacture of said alkylurea derivatives compositions and medicaments containing said alkylurea derivatives and methods for the use of said alkylurea derivatives.
    Type: Grant
    Filed: February 10, 1982
    Date of Patent: April 9, 1985
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Hans-Peter Krause, Rudiger Sitt
  • Patent number: 4479007
    Abstract: Chroman-4-ones are prepared by reacting an o-hydroxyarylcarbonyl compound with a carbonyl compound in the presence of an amine.
    Type: Grant
    Filed: July 23, 1979
    Date of Patent: October 23, 1984
    Assignee: Bayer Aktiengesellschaft
    Inventor: Hans-Joachim Kabbe
  • Patent number: 4466964
    Abstract: The invention relates to alkylurea derivatives of Formula (I), as defined in the specification, which alkylurea derivatives are useful as hypolipaemic agents. Also included in the invention are methods for the manufacture of said alkylurea derivatives compositions and medicaments containing said alkylurea derivatives and methods for the use of said alkylurea derivatives.
    Type: Grant
    Filed: September 27, 1982
    Date of Patent: August 21, 1984
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Hans-Peter Krause, Rudiger Sitt
  • Patent number: 4460607
    Abstract: The invention relates to alkylurea derivatives of Formula (I), as defined in the specification, which alkylurea derivatives are useful as hypolipaemic agents. Also included in the invention are methods for the manufacture of said alkylurea derivatives compositions and medicaments containing said alkylurea derivatives and methods for the use of said alkylurea derivatives.
    Type: Grant
    Filed: September 27, 1982
    Date of Patent: July 17, 1984
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Hans-Peter Krause, Rudiger Sitt
  • Patent number: 4415741
    Abstract: Chroman-4-ones are prepared by reacting an o-hydroxyarylcarbonyl compound with a carbonyl compound in the presence of an amine.
    Type: Grant
    Filed: January 7, 1982
    Date of Patent: November 15, 1983
    Assignee: Bayer Aktiengesellschaft
    Inventor: Hans-Joachim Kabbe
  • Patent number: 4405644
    Abstract: The invention relates primarily to pharmaceutical compositions and medicaments containing a compound of Formula (I), infra as the active ingredient. Also included in the invention are methods for combatting lipometabolic illnesses by administration of an active compound of the invention alone, in combination with a diluent or in the form of a medicament.
    Type: Grant
    Filed: December 17, 1981
    Date of Patent: September 20, 1983
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Joachim Kabbe, Erich Klauke, Hans P. Krause, Mithat Mardin, Rudiger Sitt
  • Patent number: 4377518
    Abstract: Dyestuffs of the formulaD--N.dbd.N--A Iin whichD represents the radical of a diazo component andA represents the radical of a coupling component of the formulae ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 designate hydrogen or non-ionic radicals,R designates hydrogen or an optionally substituted alkyl, cycloalkyl, aryl, aralkyl or heterocyclic radical,X designates OH or ##STR2## T designates the remaining members of a fused-on ring and Y and Z designate hydrogen, optionally substituted alkyl or optionally substituted aryl,processes for their preparation and process for pigmenting organic material using the dyestuffs of the formula I.
    Type: Grant
    Filed: September 3, 1980
    Date of Patent: March 22, 1983
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter vor der Bruck, Hans-Joachim Kabbe
  • Patent number: RE31512
    Abstract: Pseudotrisaccharides of the sisomycin type are provided which are effective an antibacterial agents, particularly against gram-negative microorganisms. The invention also includes methods for the manufacture of the pseudotrisaccharides, compositions containing said pseudotrisaccharides and methods for the treatment of warm-blooded animals using said compounds and compositions.
    Type: Grant
    Filed: May 6, 1981
    Date of Patent: January 31, 1984
    Assignee: Bayer Aktiengesellschaft
    Inventors: Peter Stadler, Karl G. Metzger, Eckart Voss, Uwe Petersen, Hans-Joachim Zeiler, Hans-Joachim Kabbe